Technology & Products

Molekuele1_150_100Tubulysins and their synthetic analogs
The recently discovered natural product class of the tubulysins show a very high cytotoxic activity against in vitro and in vivo tumour models, especially against resistant tumour cell lines. Many representatives of these natural products … read more

Molekuele2_150_100Next generation Epothilones
The FDA approved the first epothilone drug (IXEMPRA™) for BMS in October 2007. Further drug candidates of this natural products class are currently investigated in several clinical trials by several companies. Epothilones are … read more